Skip to main content
. 2008 Jan 31;111(7):3388–3394. doi: 10.1182/blood-2007-10-121285

Table 6.

Risk of MGUS for selected conditions in white and black US male veterans

N RR* 95% CI
Total autoimmune 303 1.67 1.47-1.90
    Autoantibodies detectable 233 1.78 1.54-2.06
    Systemic involvement 99 1.95 1.57-2.42
        Polymyositis/dermatomyositis 5 2.39 0.89-6.36
        Systemic sclerosis 6 4.21 1.89-9.38
    Organ involvement 143 1.62 1.35-1.94
        Autoimmune hemolytic anemia 6 2.58 1.07-6.20
        Pernicious anemia 14 1.97 1.16-3.34
    Autoantibodies not detectable 88 1.34 1.07-1.67
    Ankylosing spondylitis 13 2.02 1.14-3.56
Total infections 779 1.40 1.27-1.53
    Influenza 23 1.53 1.00-2.33
    Pneumonia 415 1.72 1.53-1.93
        2 to 4 y prior 179 2.48 2.05-3.00
        5 to 9 y prior 121 1.46 1.18-1.80
        10 or more y prior 115 1.41 1.15-1.73
    Hepatitis 28 2.10 1.36-3.25
    Meningitis 6 1.19 0.62-2.28
    Septicemia 78 1.32 1.02-1.71
    Herpes zoster 25 1.70 1.11-2.58
    Poliomyelitis 3
Total inflammatory disorders 766 1.43 1.30-1.57
    Glomerulonephritis 78 2.62 2.06-3.34
    Nephrotic syndrome 38 2.68 1.68-4.27
    Osteoarthritis 448 1.37 1.23-1.53
        2 to 4 y prior 187 1.72 1.43-2.08
        5 to 9 y prior 125 1.29 1.06-1.54
        10 or more y prior 136 1.20 0.99-1.45

— indicates RR and CI not calculated due to small numbers.

*

RR adjusted for number of visits, race, latency, attained age, and calendar time.